[Clinical observation of the treatment of infantile viral myocarditis with puerarin].
To observe the clinical effect of the treatment of infantile viral myocarditis with puerarin. Puerarin was administered intravenously together with conventional treatment in the treated group, while that of conventional treatment solely was given in the control group. Creatine kinase isoenzyme, lactate dehydrogenase isoenzyme, cardiac function and clinical manifestations before and after treatment were observed. Puerarin could significantly relieve the symptoms of patients of infantile viral myocarditis, enhance the metabolism of myocardium and improve the cardiac function. The total effective rate of the treated group was 87.04%, significantly higher than that of the control group, the difference between them was significant (P < 0.05). Puerarin can be used to treat patients with infantile viral myocarditis with a satisfactory result.